about
Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.Targeting the Twist and Wnt signaling pathways in metastatic breast cancer.Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models.Protein kinase Cα-mediated phosphorylation of Twist1 at Ser-144 prevents Twist1 ubiquitination and stabilizes it
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Carlotta A Glackin
@ast
Carlotta A Glackin
@en
Carlotta A Glackin
@es
Carlotta A Glackin
@nl
type
label
Carlotta A Glackin
@ast
Carlotta A Glackin
@en
Carlotta A Glackin
@es
Carlotta A Glackin
@nl
prefLabel
Carlotta A Glackin
@ast
Carlotta A Glackin
@en
Carlotta A Glackin
@es
Carlotta A Glackin
@nl
P31
P496
0000-0003-2009-3518